Phase II study of S-1 for elderly patients with unresectable pancreatic cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 19 Sep 2013
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 19 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 19 Mar 2013 Planned End Date 1 Apr 2014 added as reported by University Hospital Medical Information Network - Japan record.
- 04 Oct 2011 New trial record